Tonix Pharmaceuticals names George Lederman EVP of strategy and transformation
TNXP•Tonix Pharmaceuticals appointed George Lederman executive vice president of strategy and transformation, effective October 30, 2026.
1. Appointment and role
Lederman previously served as vice president of global strategy at Aliaxis and was an associate partner at McKinsey & Company. He will lead AI initiatives to improve efficiency and cut costs, while pursuing partnerships and licensing opportunities to share clinical development costs.
